C9orf72 and neurodegenerative disease: Despite this, CSF poly-GP levels have the potential to be a useful marker to distinguish C9ORF72-associated disease from other neurodegenerative diseases and may aid in the identification of C9ORF72 mutation carriers (Gendron et al., 2017; Lehmer et al., 2017).